Zdrowie i gospodarka · 27/10/2015

FDA Publishes Draft Guidance on Compounding with Bulk Drug Substances

The FDA has released a draft guidance outlining its interim policy on compounding human drug products using bulk drug substances, which will be finalized once the list of approved substances is established.